New and TALENted genome engineering toolbox

Jarryd M. Campbell, Katherine A. Hartjes, Timothy J Nelson, Xiaolei H Xu, Stephen C Ekker

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Recent advances in the burgeoning field of genome engineering are accelerating the realization of personalized therapeutics for cardiovascular disease. In the postgenomic era, sequence-specific gene-editing tools enable the functional analysis of genetic alterations implicated in disease. In partnership with high-throughput model systems, efficient gene manipulation provides an increasingly powerful toolkit to study phenotypes associated with patient-specific genetic defects. Herein, this review emphasizes the latest developments in genome engineering and how applications within the field are transforming our understanding of personalized medicine with an emphasis on cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)571-587
Number of pages17
JournalCirculation Research
Volume113
Issue number5
DOIs
StatePublished - Aug 16 2013

Fingerprint

Cardiovascular Diseases
Genome
Precision Medicine
Phenotype
Genes
Therapeutics
Gene Editing

Keywords

  • cardiovascular disease modeling
  • genome engineering
  • induced pluripotent stem cells
  • TALENs
  • zebrafish

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

New and TALENted genome engineering toolbox. / Campbell, Jarryd M.; Hartjes, Katherine A.; Nelson, Timothy J; Xu, Xiaolei H; Ekker, Stephen C.

In: Circulation Research, Vol. 113, No. 5, 16.08.2013, p. 571-587.

Research output: Contribution to journalArticle

Campbell, Jarryd M. ; Hartjes, Katherine A. ; Nelson, Timothy J ; Xu, Xiaolei H ; Ekker, Stephen C. / New and TALENted genome engineering toolbox. In: Circulation Research. 2013 ; Vol. 113, No. 5. pp. 571-587.
@article{3f7294d3d05c462889bcac627ca0ba1f,
title = "New and TALENted genome engineering toolbox",
abstract = "Recent advances in the burgeoning field of genome engineering are accelerating the realization of personalized therapeutics for cardiovascular disease. In the postgenomic era, sequence-specific gene-editing tools enable the functional analysis of genetic alterations implicated in disease. In partnership with high-throughput model systems, efficient gene manipulation provides an increasingly powerful toolkit to study phenotypes associated with patient-specific genetic defects. Herein, this review emphasizes the latest developments in genome engineering and how applications within the field are transforming our understanding of personalized medicine with an emphasis on cardiovascular diseases.",
keywords = "cardiovascular disease modeling, genome engineering, induced pluripotent stem cells, TALENs, zebrafish",
author = "Campbell, {Jarryd M.} and Hartjes, {Katherine A.} and Nelson, {Timothy J} and Xu, {Xiaolei H} and Ekker, {Stephen C}",
year = "2013",
month = "8",
day = "16",
doi = "10.1161/CIRCRESAHA.113.301765",
language = "English (US)",
volume = "113",
pages = "571--587",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - New and TALENted genome engineering toolbox

AU - Campbell, Jarryd M.

AU - Hartjes, Katherine A.

AU - Nelson, Timothy J

AU - Xu, Xiaolei H

AU - Ekker, Stephen C

PY - 2013/8/16

Y1 - 2013/8/16

N2 - Recent advances in the burgeoning field of genome engineering are accelerating the realization of personalized therapeutics for cardiovascular disease. In the postgenomic era, sequence-specific gene-editing tools enable the functional analysis of genetic alterations implicated in disease. In partnership with high-throughput model systems, efficient gene manipulation provides an increasingly powerful toolkit to study phenotypes associated with patient-specific genetic defects. Herein, this review emphasizes the latest developments in genome engineering and how applications within the field are transforming our understanding of personalized medicine with an emphasis on cardiovascular diseases.

AB - Recent advances in the burgeoning field of genome engineering are accelerating the realization of personalized therapeutics for cardiovascular disease. In the postgenomic era, sequence-specific gene-editing tools enable the functional analysis of genetic alterations implicated in disease. In partnership with high-throughput model systems, efficient gene manipulation provides an increasingly powerful toolkit to study phenotypes associated with patient-specific genetic defects. Herein, this review emphasizes the latest developments in genome engineering and how applications within the field are transforming our understanding of personalized medicine with an emphasis on cardiovascular diseases.

KW - cardiovascular disease modeling

KW - genome engineering

KW - induced pluripotent stem cells

KW - TALENs

KW - zebrafish

UR - http://www.scopus.com/inward/record.url?scp=84883335347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883335347&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.113.301765

DO - 10.1161/CIRCRESAHA.113.301765

M3 - Article

VL - 113

SP - 571

EP - 587

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 5

ER -